Canephron Urinary Tract Support relieves symptoms of medically diagnosed, localised1 urinary tract infections (UTIs), comparable with antibiotic treatment2 but without the negative consequences3. Unlike other products which only work to prevent occurrence, Canephron treats all aspects of active cystitis symptoms and reduces its occurrence.

The 4-fold effect

The anti-inflammatory, analgesic, anti-spasmodic, and bacterial flushing effects relieve all the major symptoms of localised UTIs in a comparable manner to that of antibiotics.

  • The anti-inflammatory and analgesic effects relieve burning and pain when urinating associated with cystitis. 4, 5
  • Anti-spasmodic effects reduce the urge to urinate and relax the bladder.6
  • Bacterial-flushing effects inhibit bacterial attachment and promote its removal by rinsing.7
Active ingredients

With a combination of rosemary, centaury and lovage,
Canephron has been shown to be effective in the supportive treatment of cystitis.

REFERENCES:
1 Localised (and Systemic) UTIs is the revised classification approach to UTIs developed by the EAU in their recent guideline update (2025) and adopted by
USANZ. It serves to enhance consistency in clinical practice and replaces “uncomplicated” and “complicated”
2 Wagenlehner F. M. et al., Urol Int., 2018, 101(3), 327-336.
3 Anthony WE, Wang B, Sukhum KV, et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults.
Cell Rep. 2022;39(2):110649.
4 Nausch B. et al., Phytomedicine 2019 (60) 152987, Butler et al., Urol Int 2023;107:778–784
5 Nausch B. et al., Phytomedicine 2019 (60) 152987, Alidjanov J. et al., Investig Clin Urol 2020;61:498-507
6 BrenneisC. et al., Poster 13th International Congress Ethnopharmacology, Graz 2012, Sabadash, Shulyak, Clinical Phytoscience2017 3:9
7 KünstleG. et al., Poster EAU, Mailand2013
8 Wagenlehner F. M. et al., Urol Int., 2018, 101(3), 327-336
9 Nausch et al., Antibiotics, 2022, 11, 1331
10 EAU Guidelines on Urological infections 2025
11 https://www.usanz.org.au/info-resources/position-statements-guidelines
12 Stuart Drazich-Taylor et al., Resistance to empirical antibiotics in urinary tract infections caused by Enterobacterales in the East of England, JACAntimicrobial
Resistance, Volume 7, Issue 1, February 2025, dlaf003,
Curtis SJ et al.,. Resistance to first-line antibiotic therapy among patients with uncomplicated acute cystitis in Melbourne, Australia: prevalence, predictors
and clinical impact. JAC Antimicrob Resist. 2023 Dec 28;6(1):dlad145
13 Australia’s First National Antimicrobial Resistance Strategy 2015-2019
14 Teresa M Wozniak, et al., The Increased Length of Hospital Stay and Mortality Associated With Community-Associated Infections in Australia, Open Forum
Infectious Diseases, Volume 9, Issue 5, May 2022, ofac133
15 Winston E. Anthony, et al., Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults, Cell Reports,
Volume 39, Issue 2, 2022, 110649,
16 Naber, K., et al. Clin. Phytoscience 2017
17 Höller M., et al., Antibiotics (Basel), 2021, 10(6), 685
18 Sabadash and Shulyak Clinical Phytoscience (2017) 3:9